The clinical mass spectrometry market is witnessing high growth owing to integration of omics technologies such as proteomics, metabolomics and lipidomics with mass spectrometry. Mass spectrometry based omics technologies help in identification of biomarkers for various diseases and thus play an important role in precision medicine approach. Another key trend contributing to the market growth...
Arabic
Français
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian